Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2Phase 1 2Phase 4 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Hodgkin Disease 24Lymphoma 18Testicular Neoplasms 4Teratoma 3Recurrence 3Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3HIV Infections 3Vulvar Neoplasms 2Testicular Germ Cell Tumor 2Seminoma 2Neoplasms, Germ Cell and Embryonal 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Follicular 2Head and Neck Neoplasms 2Endodermal Sinus Tumor 2Dendritic Cell Sarcoma, Interdigitating 2Carcinoma, Embryonal 2Burkitt Lymphoma 2Acquired Immunodeficiency Syndrome 2Waldenstrom Macroglobulinemia 1Ulcer 1Squamous Cell Carcinoma of Head and Neck 1Sertoli-Leydig Cell Tumor 1Sarcoma, Kaposi 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pathologic Processes 1Ovarian gynandroblastoma 1

Interventions

Cisplatin 131Cetuximab 80Radiotherapy 76Docetaxel 59Carboplatin 46pembrolizumab 45Paclitaxel 44Fluorouracil 42Radiotherapy, Intensity-Modulated 35Drug Therapy 17Radiation 14Nivolumab 14Gefitinib 14Gemcitabine 13Surgical Procedures, Operative 12Oxaliplatin 11Erlotinib Hydrochloride 11130-nm albumin-bound paclitaxel 11Pemetrexed 10Celecoxib 10Capecitabine 10Bevacizumab 10tislelizumab 9Filgrastim 9Amifostine 9Albumin-Bound Paclitaxel 9durvalumab 7atezolizumab 7Chemoradiotherapy 7toripalimab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Head and Neck Neoplasms × Bleomycin × Clear all
NCT01606566 2022-02-18

A Study to Evaluate the Safety and Efficacy of Amphinex Induced PCI of Bleomycin for Recurrent Head and Neck Cancer.

PCI Biotech AS

Phase 2 Terminated
26 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasms, Recurrence

NCT02549742 2017-01-18

Electrochemotherapy on Head and Neck Cancer

Rigshospitalet, Denmark

Phase 2 Unknown
25 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡